Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | IDO1 | P14902 | 3/20 | 0.41 |
| ▸ | PNMT | P11086 | 3/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9479134 | 0.84 | CYP3A4 (0.45) | CYP3A4CYP2A6IDO1PNMTHTT | |
| SCHEMBL1570096 | 0.83 | TAAR1 (0.52) | CYP3A4IDO1ALDH1A1 | |
| SCHEMBL1640771 | 0.82 | CYP3A4 (0.52) | CYP3A4CYP2A6IDO1PNMTHTT | |
| SCHEMBL15093979 | 0.81 | CYP3A4 (0.48) | CYP3A4CYP1A2CYP2C9MAPK1CYP2C19 | |
| Hydrochloric Acid SCHEMBL14157241 | 0.81 | TAAR1 (0.50) | CYP3A4IDO1SMN1; SMN2ALDH1A1 | |
| Hydrochloric Acid SCHEMBL31129160 | 0.80 | CYP3A4 (0.50) | CYP3A4CYP2A6IDO1PNMTHTT | |
| SCHEMBL27628619 | 0.79 | CYP3A4 (0.43) | CYP3A4CYP2A6CYP1A2CYP2C9MAPK1 | |
| SCHEMBL998743 | 0.79 | CYP3A4 (0.43) | CYP3A4CYP2A6CYP1A2CYP2C9MAPK1 | |
| SCHEMBL171203 | 0.79 | CYP3A4 (0.43) | CYP3A4CYP1A2CYP2C9MAPK1CYP2C19 | |
| SCHEMBL701343 | 0.78 | CYP2A6 (0.48) | CYP3A4CYP2A6CYP1A2CYP2C9MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 155 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117105800-B | Pendimethalin hapten, pendimethalin antigen, pendimethalin antibody and preparation method and application of pendimethalin hapten, pendimethalin antigen and pendimethalin antibody | 贵州国芯生物科技有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-117105800-A | Pendimethalin hapten, pendimethalin antigen, pendimethalin antibody and preparation method and application of pendimethalin hapten, pendimethalin antigen and pendimethalin antibody | 贵州国芯生物科技有限公司 | 2023-11-24 | — | — | CN | claimed |
| US-20120041225-A1 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | VAIDYA NITEEN A (US) | 2012-02-16 | — | — | US | claimed |
| EP-1981831-A2 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | Vaidya, Niteen A. (US) | 2008-10-22 | — | — | EP | claimed |
| WO-2007092264-A2 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | VAIDYA NITEEN A (US) | 2007-08-16 | — | — | WO | claimed |
| US-20070185346-A1 | Kit for automated resolving agent selection and method thereof | VAIDYA NITEEN A | 2007-08-09 | — | — | US | claimed |
| CN-117105800-B | Pendimethalin hapten, pendimethalin antigen, pendimethalin antibody and preparation method and application of pendimethalin hapten, pendimethalin antigen and pendimethalin antibody | 贵州国芯生物科技有限公司 | 2025-06-24 | — | — | CN | disclosed |
| US-20250136594-A1 | COMPOUNDS AND METHODS OF USE | TANGO THERAPEUTICS, INC. | 2025-05-01 | — | — | US | disclosed |
| EP-4469438-A1 | COMPOUNDS AND METHODS OF USE | Tango Therapeutics, Inc. (US) | 2024-12-04 | — | — | EP | disclosed |
| CN-115093389-B | 6-Amide chroman-3-carboxamide derivative, preparation method and application thereof | 广州医科大学 | 2024-10-18 | — | — | CN | disclosed |
| WO-2024199457-A1 | COMPOUND HAVING RING FUSED STRUCTURE, PREPARATION METHOD THEREFOR AND USE THEREOF, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF | 苏州安赛隆医药科技有限公司 | 2024-10-03 | — | — | WO | disclosed |
| CN-118724903-A | Compound with fused ring structure, its preparation method and use, and pharmaceutical composition and use | 苏州安赛隆医药科技有限公司 | 2024-10-01 | — | — | CN | disclosed |
| CN-117105800-A | Pendimethalin hapten, pendimethalin antigen, pendimethalin antibody and preparation method and application of pendimethalin hapten, pendimethalin antigen and pendimethalin antibody | 贵州国芯生物科技有限公司 | 2023-11-24 | — | — | CN | disclosed |
| EP-1097128-B1 | IMIDAMIDE DERIVATIVES | BAYER CROPSCIENCE AG (DE) | 2004-05-12 | — | — | EP | disclosed |
| WO-2004024728-A2 | PYRAZOLO[3,4-B]PYRIDINE COMPOUNDS, AND THEIR USE AS PHOSPHODIESTERASE INHIBITORS | GLAXO GROUP LIMITED (GB) | 2004-03-25 | — | — | WO | disclosed |
| US-6638979-B1 | Imidamide derivatives | BAYER AKTIENGESELLSCHAFT (DE) | 2003-10-28 | — | — | US | disclosed |
| CN-1314881-A | Imidamide derivatives | BAYER AG (DE) | 2001-09-26 | — | — | CN | disclosed |
| EP-1097128-A1 | IMIDAMIDE DERIVATIVES | Bayer Aktiengesellschaft (DE) | 2001-05-09 | — | — | EP | disclosed |
| WO-2000003976-A1 | IMIDAMIDE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2000-01-27 | — | — | WO | disclosed |
| US-4052191-A | HERBICIDE | VELSICOL CHEMICAL CORPORATION (US) | 1977-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250136594-A1 | COMPOUNDS AND METHODS OF USE | CNKSR1, UGT1A1, REV1 | CYP3A4 100/4885CYP2A6 30/4885CYP1A2 6/4885 |
| US-20120041225-A1 | KIT FOR AUTOMATED RESOLVING AGENT SELECTION AND METHOD THEREOF | ACKR3, KIT, C3AR1 | CYP3A4 292/4885CYP2A6 381/4885CYP1A2 1252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.